Founded in 1994, the Yale Diabetes Center (YDC) is a regional resource for diabetes care and education and represents the joint efforts of the Yale Schools of Medicine and Nursing, and Yale New Haven Hospital, one of the nation's leading healthcare centers. In 2008, the YDC moved to its new practice site on the 2nd floor of the Dana Building at 789 Howard Avenue.
We specialize in Type 1 and Type 2 diabetes, as well as those with pre-diabetes, metabolic syndrome, insulin resistance, and polycystic ovary syndrome. Focusing on life style interventions and employing the latest medications and technologies to treat or prevent diabetes, the YDC seeks to find teach how improve the health and well being of all its patients; we stress tight glucose control and aggressive management of other cardiovascular risk factors in order to prevent the long-term complications of diabetes.
The YDC’s Inpatient Diabetes Management Team, founded in 2005, is the only one of its kind in Connecticut. The team focuses on improving the blood glucose control of patients hospitalized at Yale-New Haven Hospital with high blood sugar.
Team members consist of nurse practitioner Linda Ferro, as well as Anne Kaisen, Leigh Bak, and Karen McAvoy, who serve as Yale-New Haven Hospital's Clinical Diabetes Nurse Specialists; endocrine fellows; and an attending endocrinologist. Rounds are conducted daily.
Yale is a national leader in the development of protocols and procedures to ensure optimal glucose control during hospitalizations. The Yale Insulin Infusion Protocol, for example, is now used by hundreds of hospitals around the world to achieve meticulous glucose control in critical care units.
Clinical research opportunities are also available for our patients, who may take advantage of ongoing clinical trials at the NIH-funded Yale Center for Clinical Investigation (YCCI).